Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

This article is a correction to:

1. A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

   1. Read original article

A corrigendum on
Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

by Liu, T., Li, Y., Niu, X., Wang, Y., Zhang, K., Fan, H., Ren, J., Li, J., Fang, Y., Li, X., and Wu, X. (2022). Front. Neurol. 13:937417. doi: 10.3389/fneur.2022.937417

In the published article, there was an error in affiliations 1 and 2. Instead of “1 Shanxi Medical University, Taiyuan, China,” it should be “2 Shanxi Medical University, Taiyuan, China.” Instead of “2 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China,” it should be “1 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.